43 unknown. 43 Phase 1, 19 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 43 | Unknown 43 |
| Phase 2 | 19 | Unknown 19 |
Follow Behavioral Symptoms: new trials by email Literature Review of Behavioral Symptoms trials Research Report on Behavioral Symptoms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treating Stress and Anxiety in Individuals With Alcohol Use Disorder (AUD) active heat, Active c tactile fiber stimulation, sham heat - Anxiety Disorders, Alcohol Use Disorder | Phase 1 | Unknown | Soovu Labs Inc. | 36 | 2024-07-15 | 2024-01-25 |
| Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care Dexmedetomidine Hydrochloride - Hyperactive Delirium, Delirium of Mixed Origin | Phase 1 / Phase 2 | Unknown | Bruyère Health Research Institute. | 50 | 2024-01-30 | 2025-04-15 |
| Focused Research On Neurofeedback Therapy In Eradicating Depression (FRONTIER) Neurofeedback - Depression | Phase 1 / Phase 2 | Unknown | UNB Sumiyoshi Jinja Mae Clinic | 30 | 2023-11-20 | 2024-08-16 |
| Northwest Therapies Trauma Psilocybin Study Compassionate Use Study Trauma - Trauma, Nervous System | Phase 1 | Unknown | NWTraumatherapies | 30 | 2023-09-03 | 2022-11-16 |
| Protecting Alzheimer Caregivers Using Technology Through Staying Sharp Staying Sharp intervention - Mild Cognitive Impairment, Dementia Alzheimers | Phase 1 / Phase 2 | Unknown | Oregon Health and Science University | 138 | 2023-04-30 | 2023-02-09 |
| Altering Default Mode Network Activity With Transcranial Focused Ultrasound to Reduce Depressive Symptoms Non-Invasive Transcranial Focused Ultrasound - Depressive Disorder, Major, Depression | Phase 1 / Phase 2 | Unknown | University of Arizona | 20 | 2023-04-27 | 2024-03-20 |
| Biological and Behavioral Outcomes of Community Nature Walks Reclaiming Nature Intervention - Stress, Psychological, Telomere Shortening | Phase 1 | Unknown | Charlotte Tate | 200 | 2023-02-01 | 2023-09-28 |
| Exploring Novel Uses of Microbiota Therapy for Managing the Side Effects of Psychiatric Pharmaceutical Interventions Acetate (Apple Cider Vinegar) - Depression, Anxiety | Phase 1 | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 10 | 2022-06-01 | 2023-10-05 |
| Testing a New Self-help Intervention for Infertility Related Distress: a Pilot Study Coping with Infertility Program - Infertility, Female | Phase 1 / Phase 2 | Unknown | University of Regina | 20 | 2021-11-01 | 2022-02-01 |
| Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 PurWet, FurFat, PurApo - Sequelae of; Infection, Post Infection Glomerulonephritis | Phase 1 / Phase 2 | Unknown | All Natural Medicine Clinic, LLC | 2000 | 2021-03-01 | 2021-05-26 |
| Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subject Ammoxetine Hydrochloride Enteric-coated Tablets, placebo enteric-coated tablets - Depression | Phase 1 | Unknown | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 36 | 2019-03-10 | 2019-02-22 |
| The Effect of Intravenous Ketamine on Non Suicidal Self Injuries. Ketamine, Midazolam - Non Suicidal Self Injury | Phase 1 / Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 30 | 2019-02-25 | 2020-01-27 |
| Ketamine for Major Depressive Disorder SHX-001 Active low dose, Placebo, SHX-001 Active High dose - Major Depressive Disorder | Phase 1 | Unknown | Shenox Pharmaceuticals, LLC | 14 | 2018-12-28 | 2019-04-25 |
| The Study About Mechanism of Transcranial Magnetic Stimulation Treatment of Depression Using Medical Imaging Transcranial magnetic stimulation (TMS), antidepressants - Depression | Phase 1 | Unknown | Xi'an Jiaotong University | 240 | 2018-03-01 | 2018-04-17 |
| Chinese Herb for the Treatment of Depression and Anxiety Disorders SZ-05, Escitalopram Pill - Depression, Anxiety | Phase 1 / Phase 2 | Unknown | Mazra Mental Health Center | 60 | 2017-08-28 | 2017-10-27 |
| Short-term Efficacy of Antidepressant in Patients Underwent TKA Duloxetine Hydrochloride - Osteoarthritis Of Knee | Phase 1 / Phase 2 | Unknown | Dalian Municipal Central Hospital | 32 | 2017-01-01 | 2017-04-14 |
| Neurokinin (NK) 1 Antagonist for Pathological Aggression for Harmful, Impulsive, and Self-/Aggressive Behaviour NK1 Antagonist, Placebo Oral Capsule - Aggression | Phase 1 / Phase 2 | Unknown | St. Joseph's Healthcare Hamilton | 50 | 2017-01-01 | 2019-04-22 |
| A Genotype Stratification Study for Pharmacokinetics and Pharmacodynamics of Amitriptyline in Healthy Male Subjects Amitriptyline - Depression | Phase 1 | Unknown | Asan Medical Center | 24 | 2015-08-01 | 2015-08-11 |
| TNS for Major Depressive Disorder: a Phase II Randomized Controlled Trial Trigeminal Nerve Stimulation (TNS) - Depressive Symptoms | Phase 1 / Phase 2 | Unknown | Santa Casa Medical School | 44 | 2014-05-01 | 2015-05-05 |
| Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress mycophenolate mofetil (MMF), Placebo - Psychological Stress, Hypertension, Renal | Phase 1 / Phase 2 | Unknown | Augusta University | 50 | 2014-04-22 | 2019-06-20 |
Showing 20 of 43. Sign in to see all of them.
Depression (31) · Anxiety Disorders (12) · Stress, Psychological (6) · Depressive Disorder, Major (4) · Stress Disorders, Post-Traumatic (4) · Caregiver Burden (2) · Conduct Disorder (2) · Dementia (2) · Pain (2) · Psychomotor Agitation (2) · Self-Injurious Behavior (2) · Substance-Related Disorders (2) · Ageusia (1) · Aggression (1) · Alcohol Drinking (1)
Behavior (42) · Mental Disorders (24) · Nervous System Diseases (8) · Pathological Conditions, Signs and Symptoms (8) · Signs and Symptoms (8) · Neurologic Manifestations (6) · Brain Diseases (4) · Central Nervous System Diseases (4) · Depressive Disorder (4) · Mood Disorders (4) · Neurocognitive Disorders (4) · Stress Disorders, Traumatic (4) · Trauma and Stressor Related Disorders (4) · Aberrant Motor Behavior in Dementia (3)
Acetates (1) · Amitriptyline (1) · Antidepressive Agents (1) · Aspirin (1) · Behavior Therapy (1) · Buprenorphine (1) · Cognitive Behavioral Therapy (1) · Coping Skills (1) · Dexmedetomidine (1) · Duloxetine Hydrochloride (1) · Escitalopram (1) · Interpersonal Psychotherapy (1) · Ketamine (1) · Midazolam (1) · Mycophenolic Acid (1)
Swarthmore College (2) · All Natural Medicine Clinic, LLC (1) · Asan Medical Center (1) · Augusta University (1) · Bruyère Health Research Institute. (1) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Charlotte Tate (1) · Dalian Municipal Central Hospital (1) · George Mason University (1) · Hearthstone Alzheimer Care (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Mazra Mental Health Center (1) · Mount Sinai Hospital, Canada (1) · NWTraumatherapies (1) · Nanjing Medical University (1)
United States (16) · Canada (6) · China (3) · Israel (3) · Australia (2) · Norway (2) · United Kingdom (2) · Brazil (1) · Japan (1) · Rwanda (1) · Switzerland (1)
Jane E. Gillham, Ph.D. (2) · Anthony Spirito, PhD (1) · Chao-Yi Wu, PhD (1) · Charlotte Keating, PhD (1) · Chenwang Jin, doctorate (1) · Chris Barker (1) · Colleen K Loo, FRANZCP, MD (1) · Corey S Mackenzie, Ph.D. (1) · David Goldstein, Ph.D. (1) · Efrat City, MD (1) · Egil W Martinsen, Prof. dr. med. (1) · Elizabeth McCauley, PHD (1) · Giao Q. Tran, Ph.D. (1) · Gregory A Harshfield, PhD (1) · Hyeongseok Lim, MD, PhD (1)
PMID 15583741, PMID 15890495, PMID 15978266, PMID 21511342, PMID 24148027, PMID 25436448, PMID 27189142, PMID 30659782, PMID 31677152, PMID 32731812, PMID 32781397, PMID 33884617, PMID 36548042, PMID 37385583, PMID 39152484, PMID 40256163, PMID 41641082
P30AG024978 (1)